Patent details

Basic Information

Publication number:

EP2653160

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP131769275

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Topical ivermectin formulations and methods for elimination and prophylaxis of body lice

French Title of Invention:

Formulations topiques d'ivermectine et procédés d'élimination et prophylaxie de souches des morpions

German Title of Invention:

Topische Ivermectin-Formulierungen und Verfahren zur Verhinderung und Prophylaxe von Körperläusen

SPC Number:

Dates

Filing date:

12/10/2007

Grant date:

27/09/2017

EP Publication Date:

23/10/2013

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/09/2017

EP B1 Publication Date:

27/09/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

12/10/2017

Expiration date:

12/10/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/09/2017

 

 

Name:

Topaz Pharmaceuticals Inc.

Address:

1209 Orange Street, Wilmington, Delaware 19801, United States (US)

Inventor

1

Name:

Spring, Nicholas

Address:

United States (US)

2

Name:

Gwozdz, Garry T.

Address:

United States (US)

Priority

1

Priority Number:

851352 P

Priority Date:

12/10/2006

Priority Country:

United States (US)

2

Priority Number:

976259 P

Priority Date:

28/09/2007

Priority Country:

United States (US)

Classification

IPC classification:

A01N 25/02; A01N 43/90; A61K 31/7048;

Publication

European Patent Bulletin

Issue number:

201739

Publication date:

27/09/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer: